United Therapeutics Corp (UTHR) awards RSUs and options to director
Rhea-AI Filing Summary
United Therapeutics Corporation director Tommy G Thompson received equity compensation on July 22, 2026, consisting of 380 restricted stock units and 1,190 stock options with an exercise price of $527.07 per share.
The awards, described as an annual non-employee director grant, vest on the earlier of the one-year anniversary of the grant or the next Annual Meeting of Shareholders, with June 25, 2027 noted as the anticipated meeting date. Each restricted stock unit represents the right to receive one share of common stock after vesting and has no expiration date.
After these awards, Thompson holds 8,480 United Therapeutics common shares directly (including 880 issued from previously deferred RSUs), plus 8,200 shares held indirectly by a trust and 5,800 shares held indirectly through a family LLC.
Positive
- None.
Negative
- None.
Insider Trade Summary
5 transactions reported
Mixed
5 txns
Insider
Thompson Tommy G
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Unit F2, F3, F4, F5 | 380 | $0.00 | $0.00 |
| Grant/Award | Stock Option F3, F4 | 1,190 | $0.00 | $0.00 |
| holding | Common Stock F1 | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Unit — 380 shares (Direct);
Stock Option — 1,190 shares (Direct);
Common Stock — 8,480 shares (Direct);
Common Stock — 8,200 shares (Indirect, by Trust);
Common Stock — 5,800 shares (Indirect, by Family LLC)
Footnotes (5)
- F1. Includes 880 shares of common stock issued on July 8, 2026, as the result of the July 7, 2023 vesting of RSUs for which the reporting person elected to defer receipt of shares.
- F2. Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
- F3. Annual non-employee director award.
- F4. Annual non-employee director awards become fully vested on the earlier to occur of (a) the one-year anniversary of the grant date; or (b) the date of the next Annual Meeting of Shareholders following the grant date. June 25, 2027 is the anticipated date of the next Annual Meeting of Shareholders.
- F5. Not applicable as restricted stock units do not have an expiration date.
Key Figures
Restricted stock units granted: 380
Stock options granted: 1,190
Option exercise price: $527.07 per share
+5 more
8 metrics
Restricted stock units granted
380
Annual non-employee director award on July 22, 2026
Stock options granted
1,190
Annual non-employee director award on July 22, 2026
Option exercise price
$527.07 per share
Stock option grant to Tommy G Thompson
Option expiration date
July 22, 2033
Expiration of newly granted stock options
Anticipated vesting reference date
June 25, 2027
Anticipated date of next Annual Meeting of Shareholders
Direct common shares held
8,480
Post-award direct holdings, including 880 shares from deferred RSUs
Indirect shares by trust
8,200
Common stock held indirectly by a trust
Indirect shares by family LLC
5,800
Common stock held indirectly through a family LLC
Key Terms
Restricted Stock Unit, Annual non-employee director award, vested, defer receipt of shares
4 terms
Restricted Stock Unit financial
"Each restricted stock unit represents the right to receive, following vesting, one share"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Annual non-employee director award financial
"Annual non-employee director award."
vested financial
"as the result of the July 7, 2023 vesting of RSUs for which the reporting person"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What equity awards did UTHR director Tommy G Thompson receive on July 22, 2026?
Tommy G Thompson received 380 restricted stock units and 1,190 stock options as an annual non-employee director award. The RSUs convert into an equal number of United Therapeutics common shares, and the options carry a set exercise price per share.
What is the exercise price and term of Tommy Thompson’s new UTHR stock options?
The new stock options have an exercise price of $527.07 per share and expire on July 22, 2033. They vest based on director service, aligning with the earlier of a one-year anniversary or the next Annual Meeting of Shareholders.
When do the new UTHR director equity awards for Tommy G Thompson vest?
The equity awards become fully vested on the earlier of the one-year anniversary of the grant date or the next Annual Meeting of Shareholders. The anticipated meeting date referenced is June 25, 2027, which serves as the expected vesting reference point.
What do the restricted stock units granted to UTHR director Tommy G Thompson represent?
Each restricted stock unit represents the right to receive one share of United Therapeutics common stock after vesting. The RSUs have no expiration date, and their value depends on the company’s share price when shares are ultimately delivered.